Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Ginekol Pol ; 91(8): 439-446, 2020.
Article in English | MEDLINE | ID: mdl-32902840

ABSTRACT

INTRODUCTION: Malignant neoplasm of the endometrium is the most common malignant neoplasm of the female reproductive system. Toll Like Receptors (TLR) play a significant role in innate and late-immunity against infections or damaged tissues. TLRs are also involved in the development of tumors in their natural microenvironment. TLRs play an important role in angiogenesis, necessary for survival and growth of the tumor. Hypoxia playing a critical role in angiogenesis, carcinogenesis, tumor progression and distant metastasis is primarily mediated through hypoxia inducible factors (HIFs). Vascular endothelial growth factor family proteins (VEGF) are also strongly involved in tumor angiogenesis and their action is strongly associated with TLR receptors. OBJECTIVES: The aim of the study was to correlate the expression of selected TLRs and VEGFR's as well as HIF1α with clinicopathological data of endometrial cancer patients. MATERIAL AND METHODS: 123 neoplastic endometrial samples were included in the study. 51 samples of healthy endometrium served as control. The expression of TLR1, TLR2, TLR3, TLR4, VEGFR1 and VEGFR2, VEGF-A and HIF1α was examined after RNA isolation at the mRNA level by Real Time-PCR. RESULTS: We have noted a significant correlation between the expression of selected TLR and VEGFR's and clinical stage as well as pathological grading of endometrial cancer. CONCLUSIONS: Received correlations confirm a significant contribution of some TLR expression and the receptor for VEGF in the pathogenesis of epithelial endometrial cancer.


Subject(s)
Endometrial Neoplasms/metabolism , Endometrium/metabolism , Receptors, Vascular Endothelial Growth Factor/metabolism , Vascular Endothelial Growth Factor Receptor-1/metabolism , Adult , Case-Control Studies , Female , Gene Expression , Humans , Signal Transduction/physiology
2.
Tumour Biol ; 42(8): 1010428320951057, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32829673

ABSTRACT

The exchange of metabolites between mitochondria and cytosol occurs through pores formed by voltage-dependent anion channel proteins. Voltage-dependent anion channels appear to be master regulators of mitochondrial bioenergetics and the intracellular flow of energy. Deregulation of voltage-dependent anion channels expression is thought to be related to mitochondrial dysfunction in cancer. The aim of this study was to investigate the mRNA and protein expression levels of VDAC1, VDAC2, and VDAC3 in relation to clinicopathological characteristics of endometrial cancer as well as the prognostic significance of voltage-dependent anion channels expression for overall survival. VDAC1 and VDAC3 expressions were significantly higher in cancer compared to normal tissues. Kaplan-Meier analysis indicated that high expression of all VDAC genes or high VDAC2 protein level predicted poor overall survival. Multivariate analysis identified the VDAC1 and VDAC2 mRNA levels as well as VDAC2 protein level as independent prognostic factors. Our results suggest that increased expression of voltage-dependent anion channels correlates with tumor progression and may serve as a potential prognostic biomarker in endometrial cancer.


Subject(s)
Endometrial Neoplasms/pathology , Mitochondria/pathology , Mitochondrial Membrane Transport Proteins/genetics , Voltage-Dependent Anion Channel 1/genetics , Voltage-Dependent Anion Channel 2/genetics , Voltage-Dependent Anion Channels/genetics , Amino Acid Sequence , Biomarkers, Tumor/genetics , Cytoplasm/metabolism , Endometrial Neoplasms/mortality , Female , Humans , Middle Aged , Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/biosynthesis , Prognosis , RNA, Messenger/genetics , Voltage-Dependent Anion Channel 1/biosynthesis , Voltage-Dependent Anion Channel 2/biosynthesis , Voltage-Dependent Anion Channels/biosynthesis
3.
J Cell Mol Med ; 24(2): 1300-1310, 2020 01.
Article in English | MEDLINE | ID: mdl-31863623

ABSTRACT

The PI3K/AKT pathway is frequently activated in endometrial carcinoma. BMI-1 (B-lymphoma Mo-MLV insertion region 1) protein affects expression of PTEN (phosphatase and tensin homolog) in some cancers, but its significance for endometrial tumorigenesis is not known. The objective of this study was to determine the relationship between BMI-1 and expression of factors affecting AKT (protein kinase B) phosphorylation level in endometrial cancer. The expression of proteins and mRNAs was investigated in endometrial cancer specimens and samples of non-neoplastic endometrial tissue by Western blot and RT-PCR, respectively. The impact of BMI-1 down-regulation on AKT phosphorylation and expression of genes coding for several phosphatases were studied in HEC1A cells. The results showed that BMI-1 depletion caused increase in PHLPP1 and PHLPP2 (PH domain and leucine-rich repeat protein phosphatases 1/2) expression and decrease in phospho-AKT (pAKT) level. In more advanced tumours with higher metastatic potential, the expression of BMI-1 was lower compared to tumours less advanced and without lymph node metastasis. There were significant inverse correlations between BMI-1 and PHLPPs, especially PHLPP1 in normal endometrial samples. The inverse correlation between BMI-1 and PHLPP1/PHLPP2 expression was observed in PTEN positive but not PTEN negative cancers. Low PHLPP2 expression in tumours predicted poorer overall survival. BMI-1 impacts on AKT phosphorylation level in endometrial cells by regulation of PHLPP expression.


Subject(s)
Biomarkers, Tumor/metabolism , Endometrial Neoplasms/pathology , Nuclear Proteins/metabolism , PTEN Phosphohydrolase/metabolism , Phosphoprotein Phosphatases/metabolism , Polycomb Repressive Complex 1/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Apoptosis , Biomarkers, Tumor/genetics , Case-Control Studies , Cell Proliferation , Endometrial Neoplasms/genetics , Endometrial Neoplasms/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , Middle Aged , Neoplasm Invasiveness , Nuclear Proteins/genetics , PTEN Phosphohydrolase/genetics , Phosphoprotein Phosphatases/genetics , Phosphorylation , Polycomb Repressive Complex 1/genetics , Prognosis , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction , Survival Rate , Tumor Cells, Cultured
4.
Tumour Biol ; 39(3): 1010428317695017, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28349832

ABSTRACT

Ten-eleven translocation proteins are α-ketoglutarate-dependent dioxygenases involved in the conversion of 5-methylcytosines (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine, and 5-carboxylcytosine that play a significant role in DNA demethylation. Deregulation of TET genes expression and changes in the level of 5-hmC are thought to be associated with the onset and progression of several types of cancer, but there are no such data related to endometrial cancer. The aim of the work was to investigate the messenger RNA expression levels of TET1, TET2, and TET3 in relation to clinicopathological characteristics of endometrial cancer as well as the correlation between expression of TET genes and the level of 5-hmC/5-mC. The prognostic significance of TETs expression for overall survival was established. We found that TET1 and TET2 messenger RNA expression was lower and TET3 was higher in cancers compared to normal tissues. Positive correlation between 5-hmC and the relative expression of TET1 and TET2 was found, but no correlation was observed in the case of TET3. Decreased expression of TET1 and TET2 was significantly associated with increased lymph node metastasis and International Federation of Gynecology and Obstetrics stage. Kaplan-Meier analysis indicated that low TET1 expression predicted poor overall survival (p = 0.038). Multivariate analysis identified the TET1 expression in endometrial cancer as an independent prognostic factor. Our results suggest that decreased expression of TET1 correlates with tumor progression and may serve as a potential prognostic biomarker in endometrial cancer.


Subject(s)
DNA Methylation/genetics , DNA-Binding Proteins/biosynthesis , Dioxygenases/biosynthesis , Endometrial Neoplasms/genetics , Mixed Function Oxygenases/biosynthesis , Proto-Oncogene Proteins/biosynthesis , 5-Methylcytosine/analogs & derivatives , 5-Methylcytosine/metabolism , Aged , Cytosine/analogs & derivatives , Cytosine/metabolism , DNA-Binding Proteins/genetics , Dioxygenases/genetics , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , Epigenesis, Genetic , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , Kaplan-Meier Estimate , Middle Aged , Mixed Function Oxygenases/genetics , Prognosis , Proto-Oncogene Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL